{
  "id": 2169326,
  "title": "Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future",
  "url": "https://urgent.news/2026/08/20/johnson-johnson-just-sent-shareholders-an-important-11-word-message-2169326",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-20T15:12:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/johnson-johnson-just-sent-shareholders-important-11-word-message-about-its-future"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsJohnson & Johnson is still dealing with the fallout from the loss of patent protection for one of its former top-selling drugs, Stelara.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future",
        "url": "https://urgent.news/2026/08/20/johnson-johnson-just-sent-shareholders-an-important-11-word-message",
        "published": "2026-08-20T14:52:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}